2 years functional study of human iPS-derived dopamine neural progenitor cells transplanted in primate Parkinson model confirm reduced symptoms

In a preclinical study lasting two years, the group of Jun TAKAHASHI at Kyoto University’s CiRA transplanted human iPS cell derived dopaminergic neurons into 7 Macaca monkeys treated with the neurotoxin MPTP, as a Parkinson disease (PD) model. Video-observations and MRI- and PET-imaging showed that PD symptoms were reduced over time, as compared to 3 controls. The team is now peparing a doctor-initiated clinical trial in the autumn of 2018.

CiRA news release, August 31, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny